Latest Breaking News On - Mark andrew white - Page 1 : comparemela.com

Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Get Free Report) have received a consensus rating of “Moderate Buy” from the nine ratings firms that are currently covering the firm, MarketBeat reports. One analyst has rated the stock with a hold rating and eight have assigned a buy rating to the company. The average 12-month price […]

TexasUnited statesJohn militelloMark andrew whiteRocket pharmaceuticals incAllspring global investments holdingsTorray investment partnersRocket pharmaceuticals company profileNasdaqAnalyst recommendations for rocket pharmaceuticalsJpmorgan chase coNews ratings for rocket pharmaceuticals dailyInstitutional investors weigh in on rocket pharmaceuticalsRocket pharmaceuticalsRocket pharmaceuticals stock performanceSecurities exchange commission